• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中空纤维作为一种口服缓释给药系统。

Hollow fibers as an oral sustained-release delivery system.

作者信息

Hussain M A, DiLuccio R C, Shefter E

机构信息

E. I. du Pont de Nemours & Company, Medical Products Department, Wilmington, Delaware 19898.

出版信息

Pharm Res. 1989 Jan;6(1):49-52. doi: 10.1023/a:1015847618671.

DOI:10.1023/a:1015847618671
PMID:2717518
Abstract

Phenylpropanolamine (PPA) bound to ion-exchange resin was encapsulated in hollow fibers made of segmented polyurethane. This system was examined as an oral sustained-release delivery system. The fibers were spun by the phase inversion process and cut into different aspect ratios (length/diameter). The U.S.P. basket dissolution method was used to evaluate the in vitro drug release kinetics and the effect of the aspect ratio on the release. For in vivo evaluation, selected fibers were orally administered to dogs in gelatin capsules. The fiber delivery system provided a sustained-release profile of plasma PPA and a longer terminal half-life when compared to an oral immediate-release formulation.

摘要

与离子交换树脂结合的苯丙醇胺(PPA)被包裹在由嵌段聚氨酯制成的中空纤维中。该系统作为口服缓释给药系统进行了研究。通过相转化法纺丝纤维,并将其切割成不同的长径比(长度/直径)。采用美国药典篮法来评估体外药物释放动力学以及长径比对释放的影响。为了进行体内评估,将选定的纤维装入明胶胶囊中口服给予犬。与口服速释制剂相比,该纤维给药系统提供了血浆PPA的缓释曲线和更长的终末半衰期。

相似文献

1
Hollow fibers as an oral sustained-release delivery system.中空纤维作为一种口服缓释给药系统。
Pharm Res. 1989 Jan;6(1):49-52. doi: 10.1023/a:1015847618671.
2
Hollow fibers as an oral sustained-release delivery system using propranolol hydrochloride.中空纤维作为一种使用盐酸普萘洛尔的口服缓释给药系统。
Pharm Res. 1989 Dec;6(12):1052-5. doi: 10.1023/a:1015982521706.
3
Sustained-release drug delivery system I: Coated ion-exchange resin system for phenylpropanolamine and other drugs.缓释药物递送系统I:用于苯丙醇胺及其他药物的包衣离子交换树脂系统。
J Pharm Sci. 1981 Apr;70(4):379-84. doi: 10.1002/jps.2600700409.
4
Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules.盐酸苯丙醇胺缓释剂型。第二部分:压制微胶囊的配方及体外释放动力学
J Microencapsul. 1994 May-Jun;11(3):335-44. doi: 10.3109/02652049409040463.
5
Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses.犬静脉注射、口服及口服控释剂量后苯丙醇胺的药代动力学
Biopharm Drug Dispos. 1987 Sep-Oct;8(5):497-505. doi: 10.1002/bdd.2510080509.
6
Polyvinyl alcohol-methyl acrylate copolymers as a sustained-release oral delivery system.聚乙烯醇-丙烯酸甲酯共聚物作为一种口服缓释给药系统。
Pharm Res. 1989 Oct;6(10):844-7. doi: 10.1023/a:1015900303534.
7
Sustained-release dosage form of phenylpropanolamine hydrochloride. Part I: Microencapsulation and in vitro release kinetics.盐酸苯丙醇胺缓释剂型。第一部分:微囊化及体外释放动力学
J Microencapsul. 1994 May-Jun;11(3):327-34. doi: 10.3109/02652049409040462.
8
In vitro and in vivo evaluation of a sustained release preparation containing phenylpropanolamine hydrochloride.含盐酸苯丙醇胺缓释制剂的体外和体内评价
J Pharmacobiodyn. 1986 Dec;9(12):947-52. doi: 10.1248/bpb1978.9.947.
9
Sustained-release phenylpropanolamine hydrochloride bilayer caplets containing the hydroxypropylmethylcellulose 2208 matrix. I. Formulation and dissolution characteristics.含羟丙基甲基纤维素2208基质的盐酸苯丙醇胺缓释双层胶囊。I. 处方与溶出特性
Chem Pharm Bull (Tokyo). 2000 May;48(5):673-7. doi: 10.1248/cpb.48.673.
10
Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules IV.(1)) Evaluation of the controlled release properties for in vivo and in vitro release systems.盐酸苯丙醇胺从乙基纤维素骨架颗粒中的释放过程分析IV. (1)体内外释放系统控释特性的评价
Chem Pharm Bull (Tokyo). 2007 Nov;55(11):1569-73. doi: 10.1248/cpb.55.1569.

引用本文的文献

1
Applicability of dielectric measurements to the adsorption of beta blockers onto a pharmaceutical grade ion-exchange resin.介电测量在β受体阻滞剂吸附到药用级离子交换树脂上的适用性。
Pharm Res. 2000 Sep;17(9):1144-7. doi: 10.1023/a:1026422116504.
2
Novel oral drug formulations. Their potential in modulating adverse effects.新型口服药物制剂。它们在调节不良反应方面的潜力。
Drug Saf. 1994 Mar;10(3):233-66. doi: 10.2165/00002018-199410030-00005.
3
Hollow fibers as an oral sustained-release delivery system using propranolol hydrochloride.

本文引用的文献

1
Sustained-release drug delivery system I: Coated ion-exchange resin system for phenylpropanolamine and other drugs.缓释药物递送系统I:用于苯丙醇胺及其他药物的包衣离子交换树脂系统。
J Pharm Sci. 1981 Apr;70(4):379-84. doi: 10.1002/jps.2600700409.
2
Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses.犬静脉注射、口服及口服控释剂量后苯丙醇胺的药代动力学
Biopharm Drug Dispos. 1987 Sep-Oct;8(5):497-505. doi: 10.1002/bdd.2510080509.
3
Periodontal therapy by local delivery of tetracycline.通过局部递送四环素进行牙周治疗。
中空纤维作为一种使用盐酸普萘洛尔的口服缓释给药系统。
Pharm Res. 1989 Dec;6(12):1052-5. doi: 10.1023/a:1015982521706.
J Clin Periodontol. 1979 Apr;6(2):83-92. doi: 10.1111/j.1600-051x.1979.tb02186.x.